ClinicalTrials.gov
public full text
Public Domain
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
This study aims to investigate the effects of a single dose of the glucagon-like 1 receptor agonist semaglutdie/Rybelsus on the hypothalamo-pituitary-adrenal axis, thus cortisol levels and other stresshormones in healthy males.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis#902563
- Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus#217211
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health#808149
- Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome#1072627
- Study of the Effects of Overfeeding on Glucocorticoids in Lean and Obese Subjects#1088623
Record · ID 1127452
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive